Lilly Together™

3.0
25 Rezensionen
1 Tsg.+
Downloads
Altersfreigabe
Jedes Alter
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot

Über diese App

Lilly Together™ is designed to help you as a Taltz® (ixekizumab), Olumiant® (baricitinib), EBGLYSS® (lebrikizumab-lbkz), or Omvoh® (mirikizumab- mrkz) user to manage your condition.

Please see Indications and Safety Summary including WARNINGS for Olumiant® (baricitinib) at https://olumiant.lilly.com/?section=isi

The Lilly Together™ app is a resource to help you manage your treatment journey. Key Lilly Together features include:

· Plan Setup: Set up your dosing plan, schedule dosing reminders, and track when to take your medication.

· Treatment Map: View your treatment map for a summary of what to expect during your first 6 months of treatment, including treatment touchpoints, recommended dosing, and symptom tracking.

· Dose/Medication Tracking: Log your injections or infusions to view if you are staying on track and taking your medication as your Healthcare Provider prescribed.

· Symptom Tracking: Track and monitor your symptoms over time. You can take photos that will not appear in your camera roll to keep all your symptom information in one location.

· Progress: The app puts you in control of tracking your progress, which may help you to have better conversations with your Healthcare provider.

· Logbook Report: Download a logbook report for a 90-day view of your symptom and dosing trends. This may help you understand the progress you're making on treatment so you can share the information with your Healthcare Provider.

· Additional Features: The app also offers savings card enrollment, helpful resources, and one-click- away customer support

The app offers savings card enrollment, features to help you track dosing and treatment progress, helpful resources, and one-click-away support with your Companion in Care™ team* who can also answer any questions you might have about injection training and provide the ongoing support you may need.

Note: This app is intended for the exclusive use of U.S. residents 18 years of age and older. Lilly Together™ is not intended to provide diagnostic and/or treatment decisions or replace the care and advice of a licensed Healthcare Provider. All medical analysis and treatment plans should be performed by a licensed Healthcare Provider.

Still have questions?
You can call for additional support at 1-844-486- 8546.

Lilly Together™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Olumiant® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Omvoh® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

EBGLYSS® and its delivery device base registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Lilly Support Services™, and Companion in Care™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates

* Your Companion in Care provided is not a medical professional. Your doctor is your source for medical advice.

PP-LU-US-0732
Aktualisiert am
09.04.2025

Datensicherheit

Was die Sicherheit angeht, solltest du als Erstes verstehen, wie Entwickler deine Daten erheben und weitergeben. Die Datenschutz- und Sicherheitspraktiken können je nach deiner Verwendung, deiner Region und deinem Alter variieren. Diese Informationen wurden vom Entwickler zur Verfügung gestellt und können jederzeit von ihm geändert werden.
Diese App kann die folgenden Datentypen an Dritte weitergeben
Personenbezogene Daten
Diese App kann die folgenden Datentypen erheben
Personenbezogene Daten, Gesundheit und Fitness und 3 andere
Daten werden bei der Übertragung verschlüsselt
Du kannst das Löschen der Daten beantragen

Bewertungen und Rezensionen

3.1
23 Rezensionen

Neuerungen

Medication and tracking support for adults with moderately to severely active Crohn’s disease and prescribed Omvoh® (mirikizumab-mrkz):
o Access information about your medication and possible savings
o Log your injections and view plan for upcoming doses
o Log and monitor your symptoms over time in the logbook
o Access a treatment map that allows you to see key steps in your treatment journey
o Create a logbook report that you can save and share outside of the app with your Healthcare Provider

Support für diese App

Informationen zum Entwickler
Eli Lilly and Company
lilly.mobile.android@gmail.com
1 Lilly Corporate Ctr Indianapolis, IN 46285-0002 United States
+1 317-670-7568

Ähnliche Apps